Molecular biology and gene transfer in atherosclerosis in the stenting era
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in International Journal of Cardiovascular Interventions
- Vol. 2 (3) , 141-152
- https://doi.org/10.1080/acc.2.3.141.152
Abstract
Atherosclerosis is the major cause of death in the developed world. Understanding the pathogenesis of atherosclerosis has been a major challenge to cardiovascular research over the past several decades. During this period a number of advances in various scientific disciplines has increased our understanding of this disease. These include improved understanding of the structural and functional components of normal vessel wall and more recently the use of cell biology and molecular biology techniques to elucidate the pathogenesis of atherosclerosis. None of these advances has been more dramatic nor has potentially more far reaching consequences as the application of molecular biology and gene technology to the practice of cardiovascular medicine. These developments have already opened new and exciting areas of vascular research and may in the future provide for earlier identification of genetic predisposition to atherosclerosis, strategic planning of preventive therapy and more tailored pharmacologic approaches for established disease.Keywords
This publication has 97 references indexed in Scilit:
- Molecular and cell biology of native coronary and vein-graft atherosclerosisCoronary Artery Disease, 1997
- Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimerʼs diseaseCurrent Opinion in Lipidology, 1995
- Hypertension and the Pathogenesis of AtherosclerosisHypertension, 1995
- Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142).Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Thrombolytic therapy with tissue-type plasminogen activator: New modes and novel variant plasminogen activatorsCurrent Opinion in Biotechnology, 1991
- Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.The Journal of cell biology, 1989
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985
- Hypothesis: Vasa Vasorum and Neovascularization of Human Coronary ArteriesNew England Journal of Medicine, 1984